Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Coronavirus woes hit metal stocks, but Tata Steel & JSW Steel may ride the storm

Ambit has initiated a buy call on Tata Steel with a target of Rs 550 which translates into an upside of over 40 percent from March 3 closing level of Rs 387 on the BSE.

March 05, 2020 / 10:55 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

The Nifty Metal index fell about 10 percent during the January 31-March 3 perid, largely impacted by the global volatility due to Coronavirus which has led to the destruction in demand. But there is still a silver lining for Tata Steel and JSW Steel.

“While being conscious of the near-term demand destruction emanating from Coronavirus, we see the supportive environment for metals from 2HCY21 on the back of expected Chinese stimulus, credit impulse, and global liquidity support,” Ambit Capital said in a report.

“We see global and domestic mill utilization scaling up through FY22, supporting spreads. Both Tata Steel (TSL) and JSW Steel (JSW) should generate >20% EBIDTA CAGR through FY22E,” said the report.

As an early cycle, metal, steel stand to benefit the most from Chinese infrastructure spend. Global cyclical recovery and re-stocking should provide added support. On the valuations front, peak earnings in FY22, 10-15% is below expectations.

Ambit has initiated a buy call on Tata Steel with a target of Rs 550 which translates into an upside of over 40 percent from March 3 closing level of Rs 387 on the BSE. It is also Amibit’s top pick on steeper Indian cost curve post

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

JSW Steel is also a buy call with a target of Rs 350 which translates into an upside of another 40 percent from March 3 closing level of Rs 245 on the BSE.
India Entering Sweet Spot:

India entering sweet spot as capacity additions to lag demand growth. Capacity additions in India through FY23E should underwhelm given: a) no material greenfield expansion and b) majors have expanded capacity through stressed asset acquisition.

“Even assuming 4.9 percent CAGR steel demand growth through FY23, compared to 5.7 percent CAGR in the previous 5 years, we expect incremental capacity additions to lag demand growth through FY23, suggesting reduced dependence on exports for volume growth,” said the note.

Ambit forecasts utilization approaching 86 percent on an effective basis by FY23E (vs 82% in FY20E), driving profitability.

Valuations:

Both Tata Steel and JSW Steel provide significant earnings growth through cycle. Ambit’s FY21E estimates for Tata Steel and JSW Steel are 10 percent below consensus on conservatism around demand destruction, but a quick V-shaped recovery could provide upside to our expectations.

“We anticipate stronger growth in FY22, with EBITDA estimates 3-5% above consensus. Both Tata Steel and JSW should generate >20% EBITDA growth through FY22, TSL on operating leverage and JSW on higher Dolvi volumes. Current valuations suggest peak earnings in FY22 10-15% below our expectations,” said the note.

Ambit sees Tata Steel as trading stock, while JSW Steel as a long-term play. Risks to the thesis include greater and longer than expected impact from Coronavirus, shallower than anticipated Chinese stimulus spending, and lower Indian steel demand growth necessitating higher dependence on exports.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347